AAAAAA
Results: 26-33/33
Authors:
Blandizzi, C
Natale, G
Gherardi, G
Lazzeri, G
Marveggio, C
Colucci, R
Carignani, D
Del Tacca, M
Citation: C. Blandizzi et al., Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury, DIG DIS SCI, 44(10), 1999, pp. 2039-2050
Authors:
Falcone, A
Allegrini, G
Antonuzzo, A
Brunetti, I
Pfanner, E
Lencioni, M
Masi, G
Danesi, R
Del Tacca, M
Conte, P
Citation: A. Falcone et al., Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery, ONCOL-BASEL, 57(3), 1999, pp. 195-201
Authors:
Blandizzi, C
Malizia, T
Lupetti, A
Pesce, D
Gabriele, M
Giuca, MR
Campa, M
Del Tacca, M
Senesi, S
Citation: C. Blandizzi et al., Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases, J PERIODONT, 70(9), 1999, pp. 960-966
Authors:
Blandizzi, C
Lazzeri, G
Colucci, R
Carignani, D
Tognetti, M
Baschiera, F
Del Tacca, M
Citation: C. Blandizzi et al., CCK1 and CCK2 receptors regulate gastric pepsinogen secretion, EUR J PHARM, 373(1), 1999, pp. 71-84
Authors:
Falcone, A
Antonuzzo, A
Danesi, R
Allegrini, G
Monica, L
Pfanner, E
Masi, G
Ricci, S
Del Tacca, M
Conte, P
Citation: A. Falcone et al., Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma, CANCER, 86(3), 1999, pp. 470-476
Authors:
Ferrari, A
Erdmann, W
Del Tacca, M
Formichi, B
Volta, CA
Ferrari, E
Bissolotti, G
Giunta, F
Citation: A. Ferrari et al., Xenon anesthesia: clinical results and recycling of gas, APPL CARD P, 7(3), 1998, pp. 153-155
Authors:
Bocci, G
Danesi, R
Benelli, U
Innocenti, F
Di Paolo, A
Fogli, S
Del Tacca, M
Citation: G. Bocci et al., Inhibitory effect of suramin in rat models of angiogenesis in vitro and invivo, CANC CHEMOT, 43(3), 1998, pp. 205-212
Authors:
Falcone, A
Pfanner, E
Brunetti, I
Allegrini, G
Lencioni, M
Galli, C
Masi, G
Danesi, D
Antonuzzo, A
Del Tacca, M
Conte, PF
Citation: A. Falcone et al., Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy, TUMORI, 84(6), 1998, pp. 666-668